Literature DB >> 30398593

Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals.

Cole Wayant1, Jared Scott1, Matt Vassar1.   

Abstract

Mesh:

Year:  2018        PMID: 30398593      PMCID: PMC6248098          DOI: 10.1001/jama.2018.12288

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The Proposal to Lower P Value Thresholds to .005.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2018-04-10       Impact factor: 56.272

2.  The continuing unethical conduct of underpowered clinical trials.

Authors:  Scott D Halpern; Jason H T Karlawish; Jesse A Berlin
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

3.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

4.  The extent and consequences of p-hacking in science.

Authors:  Megan L Head; Luke Holman; Rob Lanfear; Andrew T Kahn; Michael D Jennions
Journal:  PLoS Biol       Date:  2015-03-13       Impact factor: 8.029

  4 in total
  10 in total

1.  The Fragility Index in a Cohort of HIV/AIDS Randomized Controlled Trials.

Authors:  Cole Wayant; Chase Meyer; Rebecca Gupton; Mousumi Som; Damon Baker; Matt Vassar
Journal:  J Gen Intern Med       Date:  2019-04-29       Impact factor: 5.128

2.  Transforming the interpretation of significance in heart failure trials.

Authors:  Muhammad Shahzeb Khan; Simra Irfan; Safi U Khan; Mandeep R Mehra; Muthiah Vaduganathan
Journal:  Eur J Heart Fail       Date:  2019-11-14       Impact factor: 15.534

Review 3.  Challenges in Interpreting Obstetrics and Gynecology Literature.

Authors:  Ann M Bruno; Nathan R Blue
Journal:  Clin Obstet Gynecol       Date:  2022-03-23       Impact factor: 1.966

4.  Validation of the Computerized Pediatric Triage Tool, pediaTRI, in the Pediatric Emergency Department of Lenval Children's Hospital in Nice: A Cross-Sectional Observational Study.

Authors:  Antoine Tran; Petri Valo; Camille Rouvier; Emmanuel Dos Ramos; Emma Freyssinet; Emma Baranton; Olivier Haas; Hervé Haas; Christian Pradier; Stéphanie Gentile
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

5.  Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Database.

Authors:  Tim Lahm; Edward Hess; Anna E Barón; Thomas M Maddox; Mary E Plomondon; Gaurav Choudhary; Bradley A Maron; Roham T Zamanian; Peter J Leary
Journal:  Chest       Date:  2020-10-05       Impact factor: 9.410

6.  Impact of the p-Value Threshold on Interpretation of Trial Outcomes in Obstetrics and Gynecology.

Authors:  Ann M Bruno; Ashley E Shea; Brett D Einerson; Torri D Metz; Amanda A Allshouse; James R Scott; Nathan R Blue
Journal:  Am J Perinatol       Date:  2021-06-24       Impact factor: 3.079

7.  An Evaluation of Publication Bias in High-Impact Orthopaedic Literature.

Authors:  Jared Scott; Jake X Checketts; Craig M Cooper; Marshall Boose; Cole Wayant; Matt Vassar
Journal:  JB JS Open Access       Date:  2019-04-26

8.  Analysis of 567,758 randomized controlled trials published over 30 years reveals trends in phrases used to discuss results that do not reach statistical significance.

Authors:  Willem M Otte; Christiaan H Vinkers; Philippe C Habets; David G P van IJzendoorn; Joeri K Tijdink
Journal:  PLoS Biol       Date:  2022-02-18       Impact factor: 8.029

9.  How Robust are the Evidences that Formulate Surviving Sepsis Guidelines? An Analysis of Fragility and Reverse Fragility of Randomized Controlled Trials that were Referred in these Guidelines.

Authors:  Nang S Choupoo; Saurabh K Das; Priyam Saikia; Samarjit Dey; Sumit Ray
Journal:  Indian J Crit Care Med       Date:  2021-07

Review 10.  Using the CONSORT statement to evaluate the completeness of reporting of addiction randomised trials: a cross-sectional review.

Authors:  Matthew Vassar; Sam Jellison; Hannah Wendelbo; Cole Wayant; Harrison Gray; Michael Bibens
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.